CELSR2
CELSR2geneCELSR2 genetic variants regulate lipid retention and atherogenic lipoprotein handling, driving atherosclerotic lesion formation.
Pathway placement
Cascade stepLipid retention & oxidation
Confidencemedium
RationaleCAD and MI susceptibility locus; likely involved in lipid metabolism and atherosclerosis initiation.
Also acts inVascular inflammation
Druggability
DruggableYes
Known drugs / candidates0
Small-molecule tractableNo
Antibody tractableYes
EnsemblENSG00000143126
Assay & specimen
Class-level default (no specific cleared assay)— generic method inferred from analyte class; confirm against a specific product insert before use.
Specimen
Whole blood — gene is not a circulating analyte; measure protein product or genotype
Collection tube
K2-EDTA whole blood (lavender-top)
Method / principle
SNP genotyping / sequencing; or immunoassay of encoded protein
Reagent / substrate
Allele-specific primers/probes (TaqMan) or NGS panel; or antibody for protein
Platform
qPCR / NGS / array
Turnaround · availability
Send-out · Genotyping widely available; protein assay variable
Human genetic evidence
0.563
Open Targets association (myocardial_infarction)
13
GWAS associations
Traits: myocardial infarction
Literature evidence(3)
- Shared Genetic Liability Between Heart Failure and Myocardial Infarction Revealed by Genome-Wide Cross-Trait Analysis.Journal of cardiovascular pharmacology and therapeutics · 2026 · PMID 42141940 · doi
- From genotype to phenotype in human atherosclerosis--recent findings.Current opinion in lipidology · 2013 · PMID 24005217 · doi
- Mapping the genetic architecture of gene expression in human liver.PLoS biology · 2008 · PMID 18462017 · doi